𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Population-based prevalence of CDKN2A and CDK4 mutations in patients with multiple primary melanomas

✍ Scribed by Per Helsing; Dag Andre Nymoen; Sarah Ariansen; Solrun J. Steine; Lovise Maehle; Steinar Aamdal; Frøydis Langmark; Mitchell Loeb; Lars A. Akslen; Anders Molven; Per Arne Andresen

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
256 KB
Volume
47
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The presence of multiple primary cutaneous melanomas (MPM) has been advocated as guidance to identifying melanoma families. Frequencies of CDKN2A mutations in materials of sporadic MPM cases from pigmented lesion clinics vary between 8 and 15%. Patients with MPM have therefore been regarded as good candidates for CDKN2A mutational screening. We describe a population‐based study where all persons in Norway diagnosed with MPM between 1953 and 2004 (n = 738 alive per April 2004) were invited to participate. Three‐hundred‐and‐ninety patients (52.8%) responded confidentially. Mutations in CDKN2A were found in 6.9% of the respondents. Eighty‐one MPM patients (20.8%) reported that they belonged to melanoma families, and 17 (21.0%) of these harboured a CDKN2A mutation, compared to 3.2% of the nonfamilial cases. The probability of finding a CDKN2A mutation increased when the patients had three or more melanomas, or a young age of onset of first melanoma. We identified five novel CDKN2A variants (Ala57Gly, Pro81Arg, Ala118Val, Leu130Val, and Arg131Pro) and four that previously have been reported in melanoma families (Glu27X, Met53Ile, Arg87Trp, and Ala127Pro). A large deletion (g.13623_23772del10150) encompassing exon 1α and the 5′ part of exon 2 was detected in six patients with a family history of melanoma. Three patients, belonging to the same family, had the CDK4 Arg24His mutation. The frequency of CDKN2A mutations was lower than previously reported in other studies, an observation which probably is due to the population‐based design of our study. © 2007 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

CDKN2A (P16INK4a) and CDK4 mutation anal
CDKN2A (P16INK4a) and CDK4 mutation analysis in 131 Australian melanoma probands: Effect of family history and multiple primary melanomas
✍ Elizabeth A. Holland; Helen Schmid; Richard F. Kefford; Graham J. Mann 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB 👁 1 views

Mutation analysis of two genes involved in melanoma susceptibility (CDKN2A/p16 INK4a and CDK4) was undertaken in 131 probands with a family history of melanoma. Screening of all three exons of CDKN2A and exon 2 of CDK4 by single-strand conformation polymorphism (SSCP) analysis and/or direct sequenci

Screening of germline mutations in the C
Screening of germline mutations in the CDK4, CDKN2C and TP53 genes in familial melanoma: A clinic-based population study
✍ Anton Platz; Johan Hansson; Ulrik Ringborg 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 61 KB 👁 2 views

Germline mutations within the CDKN2A gene, coding for the cyclin-dependent kinase inhibitor p16, have been detected by screening in 8% of Swedish families with an inheritance of cutaneous melanoma (FMM) and dysplastic nevus syndrome (DNS). Contrastingly, the closely related gene CDKN2B had no diseas

New founder germline mutations of CDKN2A
New founder germline mutations of CDKN2A in melanoma-prone families and multiple primary melanoma development in a patient receiving levodopa treatment
✍ Caroline Kannengiesser; Stéphane Dalle; Marie-Thérèse Leccia; Marie Françoise Av 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB 👁 1 views

## Abstract Germline mutations in the __CDKN2A__ gene have been shown to predispose individuals to cutaneous malignant melanoma. Here, we describe three melanoma‐prone families and one isolated patient affected by multiple melanoma who carried a tandem germline mutation of __CDKN2A__ at the nucleot

BRCA2 mutations in a population-based se
BRCA2 mutations in a population-based series of patients with ocular melanoma
✍ Rodney J. Scott; Claire M. Vajdic; Bruce K. Armstrong; Christopher J. Ainsworth; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 75 KB 👁 1 views

## Abstract We studied the BRCA2 gene for germline mutations in 71 of 99 patients (72%) with ocular melanoma who were diagnosed consecutively in Australia in 1997 and 1998. Patients considered for our study fulfilled one of the following critiera: __(i)__ were 50 years of age or less at diagnosis;

Prevalence of primary Sjögren's syndrome
Prevalence of primary Sjögren's syndrome in patients with multiple sclerosis
✍ J. Miró; J. L. Peña-Sagredo; J. Berciano; S. Insúa; C. Leno; R. Velarde 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 280 KB 👁 1 views

Sixty-four consecutive patients with clinically or laboratory-supported definite multiple sclerosis (MS) were evaluated prospectively for evidence of primary Sjiigren's syndrome (SS). This diagnosis was established when a patient had objective keratoconjunctivitis sicca, xerostomia, or both together